Overview

Trial Of Misoprostol And Dinoprostone Vaginal Pessaries for Cervical Priming (TROMAD Study)

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
Most studies of labour induction with misoprostol used doses higher than 25mg and intervals of 3-4 hours. We studied a low-dose regime of 25mg misoprostol and compared its efficacy as single dose or double dose with dosing interval of 6 hours to our current regime of 3 mg dinoprostone pessary.
Phase:
Phase 3
Details
Lead Sponsor:
KK Women's and Children's Hospital
Collaborator:
National Healthcare Group, Singapore
Treatments:
Dinoprostone
Misoprostol